High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?

We report the case of a 22‐year‐old man with a diagnosis of dihydropteridine reductase (DHPR) deficiency who progressively developed movement disorders and epilepsy. Despite L‐Dopa supplementation the patient continued to show high prolactin levels, with a discrepancy between the neurological clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitturi, Nicola, Lenzini, Livia, Luisi, Concetta, Carecchio, Miryam, Gugelmo, Giorgia, Francini‐Pesenti, Francesco, Avogaro, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411106/
https://www.ncbi.nlm.nih.gov/pubmed/34485017
http://dx.doi.org/10.1002/jmd2.12236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411106/
https://www.ncbi.nlm.nih.gov/pubmed/34485017
http://dx.doi.org/10.1002/jmd2.12236

Ejemplares similares